First National Corp’s West Pharmaceutical WST Stock Holding History

First National Corp’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-65	Closed	-$7K	–	444
2019 Q1	$7K	Hold	65	–	–	﹤0.01%	368
2018 Q4	$6K	Buy	+65	New	+$7.05K	﹤0.01%	403

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

First National Corp's WST Position: Q2 2019 in Review

First National Corp sold out of West Pharmaceutical (WST) in Q2 2019, closing a stake of 65 shares — an estimated $7K sold.

First National Corp first reported a position in WST in Q4 2018 and held it in 2 quarters. The position peaked at $7K in Q1 2019. 374 funds tracked by Wall St. Rank hold WST as of Q2 2019.

First National Corp reported no remaining West Pharmaceutical position as of Q2 2019 after selling out during the quarter.
First National Corp sold 65 West Pharmaceutical shares in Q2 2019, an estimated $7K.
First National Corp first reported a position in West Pharmaceutical in Q4 2018 and held it in 2 quarters.
First National Corp's West Pharmaceutical position peaked at $7K in Q1 2019.
374 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2019.

Based on First National Corp's 13F filing for Q2 2019, filed 30 Jul 2019.